Phio Pharmaceuticals
Phio’s proprietary RNA interference (RNAi) technology makes immune cells more effective in killing tumor cells.
Launch date
Employees
Market cap
€2.6m
Enterprise valuation
(€5m) (Public information from Sep 2024)
Share price
$3.55 PHIO
Marlborough Massachusetts (HQ)
Authorizing premium user...